Thomas Edison Patent Award for dry powder inhaler design.

Merck and inventors Michael Galluppi, Scott Brown, and Peter A. Basile received an Edison Patent Award in the medical device category for “Drug products, dry powder inhalers and polyflux collider arrangements” (U.S. 9,174,012), a dry powder inhaler (DPI) that incorporates a “polyflux collider” and is capable of delivering a significantly higher amount of respirable sized drug particles to the lung than typical inhalers, specifically targeted for Asthma and COPD patients.